NVO
Another haircut, same rating
Novo Nordisk got a fresh Wall Street trim on Friday: BNP Paribas lowered its price target to DKK 295 from DKK 302 and left the stock sitting at Neutral. Not exactly a dramatic mic drop, but in a year where Novo has already been taking on water, even a small shave can feel like another reminder that the easy upside party is over.
Why investors care
Price-target cuts don’t move the business, but they do shape the vibe around a stock. And right now the vibe is: “Show me the next leg of growth.” Novo has been juggling a lot lately — pipeline questions, layoffs-then-rehiring whiplash, and a stock that’s still down sharply for the year despite Friday’s gain.
The bigger picture
This isn’t BNP Paribas declaring a bear market thesis. It’s more like an analyst saying, “We still like the furniture, just not enough to pay as much for it.” That can matter when sentiment is already fragile and every new note gets treated like a weather forecast for the shares.
Big picture: Novo’s still a heavyweight, but the market is acting like it wants proof before it pays up again.